Effects of Oxygen Atom Position in Linear Side Chains of Ansellone Analogues on HIV Latency-Reversing Activity

Authors:

Abstract
Antiretroviral therapy can manage HIV infections, but a cure remains elusive owing to viral latency. The "shock and kill" strategy uses latency-reversing agents (LRAs) to reactivate viral production toward eliminating latent HIV. However, developing novel LRA scaffolds remains a critical challenge. This study focused on a structurally simplified hydrobenzopyran analogue of ansellone A, a natural product with latency-reversing activity. To investigate the influence of incorporating ether oxygen into the alkyl chain, thought to anchor to the biological membrane, on the biological activity, we designed and synthesized a series of hydrobenzopyran analogs with varying oxygen positions in their lipophilic side chains. Biological evaluation in J-Lat 10.6 and TZM-bl cells revealed that the oxygen atom position did not considerably influence the HIV latency-reversing activity. Furthermore, none of the compounds affected cell viability. These findings suggest that ether-containing hydrobenzopyran derivatives represent a viable and synthetically flexible scaffold for the development of novel LRAs.
Funding Information
  • Takeda Science Foundation
  • Core Research for Evolutional Science and Technology (JPMJCR20R1)
  • Japan Agency for Medical Research and Development (JP25ama121054)
  • Japan Society for the Promotion of Science (21K07055, 24K09727, JP23H02608)
  • Takahashi Industrial and Economic Research Foundation
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Iwatani Naoji Foundation
  • BOMU Wellness Foundation

This publication has 30 references indexed in Scilit: